DOCSLIB.ORG

Generate Metabolic Map Poster

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Generate Metabolic Map Poster Authors: Pallavi Subhraveti Ron Caspi Peter Midford Peter D Karp An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Ingrid Keseler Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_001591825Cyc: Bacillus vietnamensis NBRC 101237 Cellular Overview Connections between pathways are omitted for legibility. Anamika Kothari sn-glycerol phosphate phosphate pro phosphate phosphate phosphate thiamine molybdate D-xylose D-ribose glutathione 3-phosphate D-mannitol L-cystine L-djenkolate lanthionine α,β-trehalose phosphate phosphate [+ 3 more] α,α-trehalose predicted predicted ABC ABC FliY ThiT XylF RbsB RS10935 UgpC TreP PutP RS10200 PstB PstB RS10385 RS03335 RS20030 RS19075 transporter transporter of molybdate of phosphate α,β-trehalose 6-phosphate L-cystine D-xylose D-ribose sn-glycerol D-mannitol phosphate phosphate thiamine glutathione α α phosphate phosphate phosphate phosphate L-djenkolate 3-phosphate , -trehalose 6-phosphate pro 1-phosphate lanthionine molybdate phosphate [+ 3 more] Metabolic Regulator Amino Acid Degradation Amine and Polyamine Biosynthesis Macromolecule Modification tRNA-uridine 2-thiolation Degradation ATP biosynthesis a mature peptidoglycan a nascent β an N-terminal- an N-terminal- a peptide with DNA combined and selenation (bacteria) L-valine degradation I -D-fructofuranose D-sedoheptulose [2Fe-2S] iron-sulfur Cofactor, Carrier, and Vitamin Biosynthesis L-arginine degradation V (meso-diaminopimelate adenosylcobinamide a purine peptidoglycan KDGP adenosylcobinamide L-methionyl-L- NMN L-methionyl-L- an N-terminal with exogenous superpathway of menaquinol-7 biosynthesis adenosylcobinamide-GDP adenosylcobinamide-GDP superpathway of coenzyme A biosynthesis I (bacteria) thiamine flavin biosynthesis I (bacteria and plants) menaquinol-9 biosynthesis ppGpp metabolism L-isoleucine degradation I L-threonine L-arginine degradation L-arginine 4-aminobutanoate 1-phosphate 1,7-bisphosphate cluster biosynthesis molybdenum Aromatic Compound Biosynthesis (arginine deiminase pathway) containing) ribonucleoside (meso-DAP bifunctional threonyl-[protein] bifunctional seryl-[protein] L-methionine DNA to form a salvage from cobinamide I salvage from cobinamide II diphosphate ADP degradation I XIII (reductive degradation degradation I cofactor biosynthesis cys 5'-triphosphate containing) adenosylcobinamide metallophosphatase/ recombinational 3-methyl-2- a 5,10- salvage III F0F1 ATP synthase: val Stickland reaction) III (arginine Holliday chorismate demethylmenaquinol-9 pppGpp chorismate biosynthesis I ile bifunctional kinase/ fructose 5'-nucleotidase: fructose junction L-cysteine desulfurase cob(II)inamide cob(II)inamide oxobutanoate methylenetetrahydrofolate GTP dipicolinate biosynthesis BVI01S_RS01215 arg thr decarboxylase/ 4-aminobutanoate bifunctional lytic type I methionyl type I methionyl type I methionyl junction thiamine demethylmenaquinone molybdate cysteine arg bifunctional adenosylcobinamide- bisphosphate BVI01S_RS05000 bisphosphate serine serine isochorismate cob(I)yrinic acid bifunctional (p)ppGpp atpB atpE atpF branched-chain- threonine agmatinase pathway) transglycosylase/ bifunctional lytic 4-hydroxy-2- aminopeptidase: aminopeptidase: aminopeptidase: resolvase RS09595 cysteine cob(I)yrinic acid thiamine methyltransferase: D-erythrose desulfurase: branched-chain- arg adenosylcobinamide phosphate aldolase: aldolase: thr thr synthase: a,c-diamide 3-methyl-2-oxobutanoate predicted synthetase/guanosine- BVI01S_RS01235 amino-acid arginine deiminase: ammonia- arginine deiminase: C40 family transglycosylase/ oxoglutarate map bifunctional map map RuvX: ruvX desulfurase: diphosphokinase: BVI01S_RS08450 molybdopterin guanosine 3'- 4-phosphate BVI01S_RS13985 amino-acid kinase/ guanylyltransferase: BVI01S_RS13780 BVI01S_RS13780 a,c-diamide hydroxymethyltransferase: bifunctional ABC 3',5'-bis(diphosphate) 3'- bifunctional 3-deoxy-7- asp atpA BVI01S_RS01245 transaminase: ilvE lyase: ilvA BVI01S_RS07215 succinate peptidase: C40 family aldolase/2- metallophosphatase/ BVI01S_RS14885 adenosyltransferase: BVI01S_RS07650 menaquinol-9 diphosphate 5'- [+ 3 isozymes] transaminase: BVI01S_RS07215 (2Z)-2-aminobut- adenosylcobinamide- type I methionyl type I methionyl type I methionyl Holliday BVI01S_RS13985 adenosyltransferase: panB 3,4-dihydroxy- phosphoheptulonate aspartate kinase: atpD BVI01S_RS01255 semialdehyde peptidase: dehydro-3-deoxy- BVI01S_RS08710 fructose- 5'-nucleotidase: fructose- BVI01S_RS15385 thiamine transporter pyrophosphohydrolase: triphosphate 3'- an [L-cysteine 3-methyl-2-oxobutanoate 2-enoate L-citrulline BVI01S_RS12875 phosphate aminopeptidase: aminopeptidase: aminopeptidase: junction serine serine [+ 3 isozymes] isochorismate BVI01S_RS15385 2-butanone- synthase/ BVI01S_RS11555 ilvE agmatine NAD-dependent phosphogluconate bisphosphate BVI01S_RS20420 bisphosphate RS09600 cob(I)yrinic acid superpathway of tetrahydrofolate biosynthesis diphosphate of molybdate: BVI01S_RS19350 diphosphatase: desulfurase]-S- ATP synthase subunit L-citrulline [+ 3 isozymes] guanylyltransferase: BVI01S_RS12875 bifunctional map 1-(β-D map map resolution resolvaseof thr thr cob(I)yrinic acid asp 4-phosphate chorismate mutase: [+ 3 isozymes] (3S)-3-methyl-2- ornithine succinate- aldolase: aldolase: aldolase: an S-sulfanyl-[L- a,c-diamide modB modA BVI01S_RS19350 sulfanyl-L-cysteine B: BVI01S_RS09665 BVI01S_RS08695 [+ 3 isozymes] adenosylcobinamide ribofuranosyl) recombinationalRecU: recU 2-succinyl-6- a,c-diamide 2-dehydropantoate synthase/GTP molybdopterin BVI01S_RS21200 oxopentanoate carbamoyltransferase: agmatinase: semialdehyde BVI01S_RS00415 BVI01S_RS15835 BVI01S_RS15835 cysteine desulfurase] adenosyltransferase: 3-deoxy- L-aspartyl-4-phosphate kinase/ hydroxy-2, 4- aspartate 1- cyclohydrolase II: adenine speB a mature peptidoglycan a mature peptidoglycan an N-terminal L- nicotinamide an N-terminal junction BVI01S_RS08690 adenosyltransferase: 2-dehydropantoate molybdate ATP ornithine argF dehydrogenase: bifunctional adenosylcobinamide- scaffold protein cyclohexadiene- [corrinoid decarboxylase: GTP BVI01S_RS15110 dinucleotide D-arabino- 2-iminobutanoate with (L-alanyl-γ-D- strand (non- a mature a nascent met threonyl-[protein] met L-seryl-[protein] met a peptide formation of two trp RS20045 trp BVI01S_RS08690 2-reductase: carbamoyltransferase: BVI01S_RS05370 adenosylcobinamide phosphate D-erythrose for iron-sulfur 1-carboxylate adenosyltranferase]- panD GTP ppGpp heptulosonate aspartate-semialdehyde a [TusA sulfur- isobutanoyl-CoA putrescine glutamyl-meso-2,6- reducing terminus) peptidoglycan peptidoglycan D-glyceraldehyde DHAP D-glyceraldehyde DHAP intact strands [corrinoid BVI01S_RS07940 2,5-diamino-6-(5-phospho-D- argF L-ornithine kinase/ pyruvate 4-phosphate cob(II)inamide molybdopterin 7-phosphate dehydrogenase: asd (2S)-2- diaminopimeloyl-D- (meso-DAP 3-phosphate guanylyltransferase: cluster assembly: synthase: menH adenosyltranferase]- GTP carrier protein]-S- succinate adenosylcobinamide- with (L-alanyl- β ribosylamino)pyrimidin-4(3H)-one 3-dehydroquinate BVI01S_RS08695 BVI01S_RS20400 (R)-pantoate -alanine cyclohydrolase molybdotransferase sulfanyl-L-cysteine methylbutanoyl-CoA ornithine--oxo-acid alanine) tetrapeptide γ-D-glutamyl- containing) with 2-succinyl-5- cob(II)inamide bifunctional nucleoside- synthase: carbamoyl phosphate adenosyl-cobinamide F0F1 ATP an S-sulfanyl-[cysteine I FolE: folE MoeA: L-aspartate 4-semialdehyde transaminase: meso-2,6- GlcNAc terminus H + H + enolpyruvyl- diaminohydroxyphosphoribosylaminopyrimidine GDP L-ornithine guanylyltransferase: synthase desulfurase]-[disordered- 7,8- BVI01S_RS17775 diphosphate BVI01S_RS08425 phosphate 2-oxobutanoate BVI01S_RS13965 diaminopimeloyl- phosphate 6-hydroxy-3- [corrinoid deaminase/5-amino-6-(5-phosphoribosylamino) pyrophosphokinase: bifunctional (p)ppGpp methylacrylyl-CoA BVI01S_RS08710 form scaffold pantoate--beta- dihydroneopterin superpathway of thiamine diphosphate biosynthesis II kinase: ndk D-alanine) cyclohexene- adenosyltranferase]- synthetase/guanosine- 3-dehydroquinate 4-hydroxy- a [TusD sulfur- carbamoyl L-glutamate-5- protein] complex [corrinoid alanine ligase: 3'-triphosphate uracil reductase RibD: ribD MoO - BVI01S_RS19350 (E)-2- adenosyl- cob(I)inamide 2 tetrahydrodipicolinate enoyl-CoA phosphate synthase: tetrapeptide [cysteine desulfurase]-S- 1-carboxylic- adenosyltranferase]- molybdopterin 3',5'-bis(diphosphate) 3'- carrier protein]-S- methylcrotonoyl-CoA semialdehyde cobinamide H + RS09665 H + BVI01S_RS08305 5-amino-6-(5-phospho- a [ThiS sulfur- type II 3- synthase: dapA hydratase: BVI01S_RS12380 sulfanylcysteine:[acceptor acid synthase: cob(I)yrinic acid cob(I)inamide cys cofactor pyrophosphohydrolase: sulfanyl-L-cysteine enoyl-CoA phosphate a purine D-ribosylamino)uracil carrier protein] dehydroquinate (2S,4S)-4-hydroxy-2,3,4,5- BVI01S_RS20125 BVI01S_RS12385 L-tryptophan degradation to protein]-cysteine menD a,c-diamide D-ribulose 5-phosphate BVI01S_RS19350 hydratase: propanoyl-CoA ribonucleoside cob(I)yrinic acid 7,8- bifunctional dehydratase: aroQ 2-amino-3-carboxymuconate sulfurtransferase: 2-succinyl-5- adenosyltransferase: (R)-pantothenate sulfur carrier cysteine tetrahydrodipicolinate
Load more

Recommended publications
  • METACYC ID Description A0AR23 GO:0004842 (Ubiquitin-Protein Ligase
    Electronic Supplementary Material (ESI) for Integrative Biology This journal is © The Royal Society of Chemistry 2012 Heat Stress Responsive Zostera marina Genes, Southern Population (α=0.
    [Show full text]
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
    [Show full text]
  • A Review on Agmatinase Inhibitors
    www.ijcrt.org © 2020 IJCRT | Volume 8, Issue 12 December 2020 | ISSN: 2320-2882 A review on Agmatinase inhibitors 1Sunnica Biswas, 2Mr. R. T. Lohiya, 3Dr. Milind Umekar *1&2 Department Of Pharmaceutical Chemistry Smt. Kishoriti Bhoyar College of Pharmacy, Kamptee, Dst. Nagpur, 441002 Abstract : Agmatine is the product of arginine decarboxylation and can be hydrolyzed by agmatinase to putrescine, the precursor for biosynthesis of higher polyamines, spermidine, and spermine. Besides being an intermediate in polyamine metabolism, recent findings indicate that agmatine may play important regulatory roles in mammals. Agmatine, 4-aminobutyl guanidine, has recently been found in various mammalian organs and is thought to act as a neurotransmitter or neuromodulatory agent. The present study is to do a review on agmatine and its synthesized analogues till now for agmatinase inhibitory action. Agmatinase is a binuclear manganese metalloenzyme and belongs to the ureohydrolase superfamily that includes arginase, formiminoglutamase, and proclavaminate amidinohydrolase. Compared with a wealth of structural information available for arginases, no three dimensional structure of agmatinase has been reported. Agmatinase is an enzyme which blocks the mammalian agmatine which is ultimately responsible for the agmatine degradation in the body. Agmatinase is an enzyme which regulates the half life of agmatine in the brain. Hence a selective inhibitor of brain agmatinase is required. Several derivatives of agmatine are synthesized previously for agmatinase inhibitory activity but none of them showed selective inhibition. PZC (Piperazinecarboxamidine) is a derivative of agmatine or guanidine is expected to show selective inhibition of human agmatinase. A detailed review is carried out in order to understand the agmatinase inhibitor.
    [Show full text]
  • Peroxisomal Proliferator–Activated Receptor- Upregulates
    Peroxisomal Proliferator–Activated Receptor-␥ Upregulates Glucokinase Gene Expression in ␤-Cells Ha-il Kim,1 Ji-Young Cha,1 So-Youn Kim,1 Jae-woo Kim,1 Kyung Jin Roh,2 Je-Kyung Seong,2 Nam Taek Lee,3 Kang-Yell Choi,1 Kyung-Sup Kim,1 and Yong-ho Ahn1 Thiazolidinediones, synthetic ligands of peroxisomal because of severe hyperglycemia (2,3). Adenovirus-medi- proliferator–activated receptor-␥ (PPAR-␥), improve ated expression of GLUT2 and GK in IL cells results in peripheral insulin sensitivity and glucose-stimulated gaining of glucose sensitivity (4). Thus, GLUT2 and GK are insulin secretion in pancreatic ␤-cells. To explore the important in glucose sensing of ␤-cells. However, GLUT2, role of PPAR-␥ in glucose sensing of ␤-cells, we have being a low-affinity, high-capacity glucose transporter, is ␤ ␤ dissected the -cell–specific glucokinase ( GK) pro- believed to play a more permissive role in glucose sensing, moter, which constitutes glucose-sensing apparatus in pancreatic ␤-cells, and identified a peroxisomal prolif- allowing rapid equilibration of glucose across the plasma erator response element (PPRE) in the promoter. The membrane. GK traps glucose in ␤-cells by phosphorylation GK-PPRE is located in the region between ؉47 and (5) and is the flux-controlling enzyme for glycolysis in␤ ؉68 bp. PPAR-␥/retinoid X receptor-␣ heterodimer ␤-cells (4). Thus, it serves as the gatekeeper for metabolic binds to the element and activates the ␤GK promoter. signaling, suggesting that GK rather than GLUT2 is directly The ␤GK promoter lacking or having mutations in PPRE ␥ ␥ responsible for the insulin secretion in response to in- cannot be activated by PPAR- .
    [Show full text]
  • Remodeling Adipose Tissue Through in Silico Modulation of Fat Storage For
    Chénard et al. BMC Systems Biology (2017) 11:60 DOI 10.1186/s12918-017-0438-9 RESEARCHARTICLE Open Access Remodeling adipose tissue through in silico modulation of fat storage for the prevention of type 2 diabetes Thierry Chénard2, Frédéric Guénard3, Marie-Claude Vohl3,4, André Carpentier5, André Tchernof4,6 and Rafael J. Najmanovich1* Abstract Background: Type 2 diabetes is one of the leading non-infectious diseases worldwide and closely relates to excess adipose tissue accumulation as seen in obesity. Specifically, hypertrophic expansion of adipose tissues is related to increased cardiometabolic risk leading to type 2 diabetes. Studying mechanisms underlying adipocyte hypertrophy could lead to the identification of potential targets for the treatment of these conditions. Results: We present iTC1390adip, a highly curated metabolic network of the human adipocyte presenting various improvements over the previously published iAdipocytes1809. iTC1390adip contains 1390 genes, 4519 reactions and 3664 metabolites. We validated the network obtaining 92.6% accuracy by comparing experimental gene essentiality in various cell lines to our predictions of biomass production. Using flux balance analysis under various test conditions, we predict the effect of gene deletion on both lipid droplet and biomass production, resulting in the identification of 27 genes that could reduce adipocyte hypertrophy. We also used expression data from visceral and subcutaneous adipose tissues to compare the effect of single gene deletions between adipocytes from each
    [Show full text]
  • METABOLIC EVOLUTION in GALDIERIA SULPHURARIA By
    METABOLIC EVOLUTION IN GALDIERIA SULPHURARIA By CHAD M. TERNES Bachelor of Science in Botany Oklahoma State University Stillwater, Oklahoma 2009 Submitted to the Faculty of the Graduate College of the Oklahoma State University in partial fulfillment of the requirements for the Degree of DOCTOR OF PHILOSOPHY May, 2015 METABOLIC EVOLUTION IN GALDIERIA SUPHURARIA Dissertation Approved: Dr. Gerald Schoenknecht Dissertation Adviser Dr. David Meinke Dr. Andrew Doust Dr. Patricia Canaan ii Name: CHAD M. TERNES Date of Degree: MAY, 2015 Title of Study: METABOLIC EVOLUTION IN GALDIERIA SULPHURARIA Major Field: PLANT SCIENCE Abstract: The thermoacidophilic, unicellular, red alga Galdieria sulphuraria possesses characteristics, including salt and heavy metal tolerance, unsurpassed by any other alga. Like most plastid bearing eukaryotes, G. sulphuraria can grow photoautotrophically. Additionally, it can also grow solely as a heterotroph, which results in the cessation of photosynthetic pigment biosynthesis. The ability to grow heterotrophically is likely correlated with G. sulphuraria ’s broad capacity for carbon metabolism, which rivals that of fungi. Annotation of the metabolic pathways encoded by the genome of G. sulphuraria revealed several pathways that are uncharacteristic for plants and algae, even red algae. Phylogenetic analyses of the enzymes underlying the metabolic pathways suggest multiple instances of horizontal gene transfer, in addition to endosymbiotic gene transfer and conservation through ancestry. Although some metabolic pathways as a whole appear to be retained through ancestry, genes encoding individual enzymes within a pathway were substituted by genes that were acquired horizontally from other domains of life. Thus, metabolic pathways in G. sulphuraria appear to be composed of a ‘metabolic patchwork’, underscored by a mosaic of genes resulting from multiple evolutionary processes.
    [Show full text]
  • Agmatinase Sirna (H): Sc-60060
    SANTA CRUZ BIOTECHNOLOGY, INC. Agmatinase siRNA (h): sc-60060 BACKGROUND STORAGE AND RESUSPENSION Agmatinase (also known as agmatine ureohydrolase) results from the decar- Store lyophilized siRNA duplex at -20° C with desiccant. Stable for at least boxylation of L-arginine by arginine decarboxylase to form a metabolic inter- one year from the date of shipment. Once resuspended, store at -20° C, mediate in the biosynthesis of putresine and higher polyamines (spermidine avoid contact with RNAses and repeated freeze thaw cycles. and spermine). Agmatinase has been shown to play a role in several important Resuspend lyophilized siRNA duplex in 330 µl of the RNAse-free water biochemical processes in humans, ranging from effects on the central nervous provided. Resuspension of the siRNA duplex in 330 µl of RNAse-free water system to cell proliferation in cancer and viral replication. Agmatinase cat- makes a 10 µM solution in a 10 µM Tris-HCl, pH 8.0, 20 mM NaCl, 1 mM alyzes the hydrolysis of agmatine to putresine and urea and is a major target EDTA buffered solution. for drug therapy. Human Agmatinase retains about 30% identity to bacterial agmatinases and less than 20% identity to mammalian arginases. Residues APPLICATIONS required for binding of Mn2+ at the active site in bacterial Agmatinase and other members of the arginase superfamily are fully conserved in human Agmatinase siRNA (h) is recommended for the inhibition of Agmatinase Agmatinase. Agmatinase mRNA is most abundant in human liver and kidney, expression in human cells. but is also expressed in several other tissues, including skeletal muscle and brain.
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Different Munc18 Proteins Mediate Baseline and Stimulated Airway Mucin Secretion
    Different Munc18 proteins mediate baseline and stimulated airway mucin secretion Ana M. Jaramillo, … , Michael J. Tuvim, Burton F. Dickey JCI Insight. 2019;4(6):e124815. https://doi.org/10.1172/jci.insight.124815. Research Article Cell biology Pulmonology Graphical abstract Find the latest version: https://jci.me/124815/pdf RESEARCH ARTICLE Different Munc18 proteins mediate baseline and stimulated airway mucin secretion Ana M. Jaramillo,1,2 Lucia Piccotti,1 Walter V. Velasco,1 Anna Sofia Huerta Delgado,3 Zoulikha Azzegagh,1 Felicity Chung,4 Usman Nazeer,1 Junaid Farooq,1 Josh Brenner,1 Jan Parker-Thornburg,5 Brenton L. Scott,1 Christopher M. Evans,6 Roberto Adachi,1 Alan R. Burns,7 Silvia M. Kreda,4 Michael J. Tuvim,1 and Burton F. Dickey1 1Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 2Institute of Bioscience and Technology, Texas A&M University Health Science Center, Houston, Texas, USA. 3Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico. 4Marsico Lung Institute/Cystic Fibrosis Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 5Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 6Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver School of Medicine, Aurora, Colorado, USA. 7College of Optometry, University of Houston, Houston, Texas, USA. Airway mucin secretion is necessary for ciliary clearance of inhaled particles and pathogens but can be detrimental in pathologies such as asthma and cystic fibrosis. Exocytosis in mammals requires a Munc18 scaffolding protein, and airway secretory cells express all 3 Munc18 isoforms.
    [Show full text]
  • Upregulated Kynurenine Pathway Enzymes in Aortic Atherosclerotic Aneurysm: Macrophage Kynureninase Downregulates Inflammation
    The official journal of the Japan Atherosclerosis Society and the Asian Pacific Society of Atherosclerosis and Vascular Diseases Original Article J Atheroscler Thromb, 2021; 28: 000-000. http://doi.org/10.5551/jat.58248 Upregulated Kynurenine Pathway Enzymes in Aortic Atherosclerotic Aneurysm: Macrophage Kynureninase Downregulates Inflammation Masanori Nishimura1, 2, Atsushi Yamashita2, Yunosuke Matsuura3, Junichi Okutsu4, Aiko Fukahori4, Tsuyoshi Hirata4, Tomohiro Nishizawa5, Hirohito Ishii1, Kazunari Maekawa2, Eriko Nakamura2, Kazuo Kitamura3, Kunihide Nakamura1 and Yujiro Asada2 1Division of Cardiovascular Surgery, Department of Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan 2Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan 3Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan 4Translational Research Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan 5Specialty Medicine Research Laboratories I, Daiichi Sankyo Co., Ltd., Tokyo, Japan Aims: Inflammation and hypertension contribute to the progression of atherosclerotic aneurysm in the aorta. Vascular cell metabolism is regarded to modulate atherogenesis, but the metabolic alterations that occur in ath- erosclerotic aneurysm remain unknown. The present study aimed to identify metabolic pathways and metabo- lites in aneurysmal walls and examine their roles in atherogenesis. Methods: Gene expression using microarray and metabolite levels in the early atherosclerotic lesions and aneu- rysmal walls obtained from 42 patients undergoing aortic surgery were investigated (early lesion n=11, aneu- rysm n=35) and capillary electrophoresis–time-of-flight mass spectrometry (early lesion n=14, aneurysm n=38). Using immunohistochemistry, the protein expression and localization of the identified factors were examined (early lesion n=11, non-aneurysmal advanced lesion n=8, aneurysm n=11).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0155567 A1 Burk Et Al
    US 2014O155567A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0155567 A1 Burk et al. (43) Pub. Date: Jun. 5, 2014 (54) MICROORGANISMS AND METHODS FOR (60) Provisional application No. 61/331,812, filed on May THE BIOSYNTHESIS OF BUTADENE 5, 2010. (71) Applicant: Genomatica, Inc., San Diego, CA (US) Publication Classification (72) Inventors: Mark J. Burk, San Diego, CA (US); (51) Int. Cl. Anthony P. Burgard, Bellefonte, PA CI2P 5/02 (2006.01) (US); Jun Sun, San Diego, CA (US); CSF 36/06 (2006.01) Robin E. Osterhout, San Diego, CA CD7C II/6 (2006.01) (US); Priti Pharkya, San Diego, CA (52) U.S. Cl. (US) CPC ................. CI2P5/026 (2013.01); C07C II/I6 (2013.01); C08F 136/06 (2013.01) (73) Assignee: Genomatica, Inc., San Diego, CA (US) USPC ... 526/335; 435/252.3:435/167; 435/254.2: (21) Appl. No.: 14/059,131 435/254.11: 435/252.33: 435/254.21:585/16 (22) Filed: Oct. 21, 2013 (57) ABSTRACT O O The invention provides non-naturally occurring microbial Related U.S. Application Data organisms having a butadiene pathway. The invention addi (63) Continuation of application No. 13/101,046, filed on tionally provides methods of using Such organisms to produce May 4, 2011, now Pat. No. 8,580,543. butadiene. Patent Application Publication Jun. 5, 2014 Sheet 1 of 4 US 2014/O155567 A1 ?ueudos!SMS |?un61– Patent Application Publication Jun. 5, 2014 Sheet 2 of 4 US 2014/O155567 A1 VOJ OO O Z?un61– Patent Application Publication US 2014/O155567 A1 {}}} Hººso Patent Application Publication Jun.
    [Show full text]
  • Development of a Phage Display Library for Discovery of Antigenic Brucella Peptides Jeffrey Williams Iowa State University
    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2018 Development of a phage display library for discovery of antigenic Brucella peptides Jeffrey Williams Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Microbiology Commons Recommended Citation Williams, Jeffrey, "Development of a phage display library for discovery of antigenic Brucella peptides" (2018). Graduate Theses and Dissertations. 16896. https://lib.dr.iastate.edu/etd/16896 This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Development of a phage display library for discovery of antigenic Brucella peptides by Jeffrey Williams A thesis submitted to the graduate faculty in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Major: Microbiology Program of Study Committee: Bryan H. Bellaire, Major Professor Steven Olsen Steven Carlson The student author, whose presentation of the scholarship herein was approved by the program of study committee, is solely responsible for the content of this thesis. The Graduate College will ensure this thesis is globally accessible and will not permit alterations after a degree is conferred. Iowa State University
    [Show full text]